Morgan Stanley
MDCX

Morgan Stanley’s Medicus Pharma MDCX Stock Holding History

Morgan Stanley’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456 Sell
1,022
-4,446
-81% -$1.57K ﹤0.01% 7687
2026
Q1 		$2.51K Sell
5,468
-12,838
-70% -$13.4K ﹤0.01% 7285
2025
Q4 		$28K Buy
18,306
+12,338
+207% +$26.4K ﹤0.01% 6596
2025
Q3 		$13.8K Sell
5,968
-5,762
-49% -$14.4K ﹤0.01% 6805
2025
Q2 		$35.1K Buy
+11,730
New +$46.8K ﹤0.01% 6481

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Morgan Stanley's MDCX Position: Q2 2026 in Review

Morgan Stanley reduced its Medicus Pharma (MDCX) stake by 81% in Q2 2026, selling an estimated $1.57K and leaving 1,022 shares worth $456. The position accounts for ﹤0.01% of the portfolio, ranked #7687.

Morgan Stanley first reported a position in MDCX in Q2 2025 and has held it in 5 quarters since. The position peaked at $35.1K in Q2 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Morgan Stanley held 1,022 shares of Medicus Pharma worth $456 as of Q2 2026.
  • Morgan Stanley sold 4,446 Medicus Pharma shares in Q2 2026, an estimated $1.57K.
  • Medicus Pharma made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7687 holding.
  • Morgan Stanley first reported a position in Medicus Pharma in Q2 2025 and has held it in 5 quarters since.
  • Morgan Stanley's Medicus Pharma position peaked at $35.1K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.